Panel rejects new weight-loss drug
501618
Federal health advisers unanimously rejected a weight-loss drug Wednesday after hearing testimony that it increases the risk of suicidal thoughts, even in patients without a history of depression. The manufacturer, Sanofi-Aventis SA, further failed to show the drug rimonabant is safe, the panel said.
252815
The Food and Drug Administration has told a researcher that he cannot be part of an advisory panel that will review the safety of a class of drugs used to treat arthritis and pain.
73292
Federal advisers rejected Merck &amp; Co.'s quest to become the first American drug maker to sell cholesterol-fighting statins over the counter, saying the company's own studies raised potential health risks while offering modest life-saving benefits.
696865
Federal health advisers recommended against over-the-counter sales of a cholesterol drug, saying that patients need medical guidance in treating a condition that has no symptoms and may require drugs for life to stay healthy.
336778
U.S. FDA staff reviewers on Tuesday  said data on a new non-Hodgkin's lymphoma drug made by Inex  Pharmaceuticals Corp. and Enzon Pharmaceuticals Inc. may be  unreliable due to the trial's structure and size.
256331
A US regulatory advisory panel has rejected Procter &amp; Gamble&#39;s female sexual dysfunction patch, saying the potential long-term risks of the hormone treatment outweighed the benefits.
398593
U.S. regulators on Friday turned  down AstraZeneca Plc's  AZN.L AZN.N anti-clotting drug  Exanta, following the advice of an advisory panel on which some  members had voiced doubt about the drug's safety and  effectiveness.
282047
A panel of nutrition specialists proposed new US dietary guidelines yesterday that acknowledge a link between soft drinks and weight gain, but stopped
477368
BETHESDA, Md.  - A U.S. panel of medical experts  recommended on Friday that U.S. regulators reject AstraZeneca's  AZN.L AZN.N application to sell its anti-clotting drug  Exanta.
738801
SAN DIEGO -- A new obesity wonder pill could become one of the best selling drugs on the market if it lives up to its clinical trials.
216097
The Food and Drug Administration recently approved the first nonprescription drug for weight loss. Alli (pronounced AL-eye) is slated to hit shelves this year, according to its maker, GlaxoSmithKline (GSK). That move has been denounced by some who say it should not be made so readily available because of limited efficacy and safety concerns....
50781
Concerns about side effects discourage many women at high risk for breast cancer from taking tamoxifen, says a study in the Dec. 14 issue of the Journal of Clinical Oncology.
511861
Reminyl, a drug approved for use against Alzheimer's disease, was found to be ineffective for patients suffering from chronic fatigue syndrome, a study said on Tuesday.
445999
The Food and Drug Administration (FDA) learned yesterday from AstraZeneca that a large clinical trial comparing Iressa (gefitinib) with placebo in patients with non-small cell lung cancer who had failed other courses of cancer therapy showed no survival
471279
The Thursday night rejection of Proctor &amp; Gamble&#39;s (PG:NYSE - news - research) female testosterone sex-drive patch Intrinsa by a Food and Drug Administration advisory panel will almost certainly delay efforts by BioSante to develop its own product, a
280913
SILVER SPRING, Maryland  - A U.S. advisory panel urged the government on Thursday to reject Merck & Co Inc's latest bid to sell the first cholesterol-lowering drug without a prescription.
687565
NEW YORK - A US Food and Drug Administration advisory panel rejected Procter &amp; Gamble&#39;s testosterone patch to treat female sexual dysfunction.